Related Experiment Video
Updated: Feb 5, 2026

Identifying Coronary Artery Calcification on Non-gated Computed Tomography Scans
Published on: August 28, 2018
Bisphosphonate therapy in an infant with generalized arterial calcification with an ABCC6 mutation
S Akhtar Ali1, C Ng2, J K Votava-Smith3
1Center For Endocrinology, Diabetes and Metabolism, Children's Hospital Los Angeles and Keck School of Medicine of University of Southern California, Los Angeles, CA, USA.
Insights
Generalized arterial calcification of infancy (GACI) due to ABCC6 mutations can be treated with early bisphosphonate therapy. This rare genetic disorder requires prompt intervention for improved survival and management.
Area of Science:
- Genetics
- Pediatrics
- Cardiology
Background:
- Generalized arterial calcification of infancy (GACI) is a rare, often fatal, genetic disorder.
- Mutations in ENPP1 and ABCC6 genes are known causes of GACI.
- Limited data exists on bisphosphonate treatment efficacy in ABCC6-positive GACI cases.
Observation:
- A patient with ABCC6-positive GACI, a recipient twin of twin-to-twin transfusion syndrome, presented with severe aortic and pulmonary artery calcification and stenosis.
- Disease progression was monitored via echocardiographic outflow tract gradients.
- The patient received early intravenous and oral bisphosphonate therapy (pamidronate and etidronate).
Findings:
- Despite initial fetal interventions, progressive calcification necessitated surgical repair of the aorta and pulmonary artery at 4 months.
- The patient demonstrated positive post-operative outcomes with continued bisphosphonate therapy and no reported side effects.
- Molecular testing confirmed an ABCC6 mutation, while her asymptomatic twin carried the same mutation.
Implications:
- Early and aggressive bisphosphonate therapy is crucial for improving survival in infantile arterial calcinosis, regardless of the underlying gene mutation (ABCC6 or ENPP1).
- Echocardiography serves as a valuable tool for monitoring disease progression through arterial gradients.
- Molecular testing is essential for identifying potential co-morbidities and guiding future pregnancy management.
Abstract:
Generalized arterial calcification of infancy (GACI) is a rare genetic disorder with high infantile mortality, described to be due to ENPP1, and less commonly ABCC6 mutations. Bisphosphonate treatment has been described to improve survival in ENPP1-positive GACI patients, but few studies have described bisphosphonate treatment in ABCC6-positive patients. Without therapy, patients will die before 6 months of age. Our patient is now 3 years old, former recipient twin of twin-to-twin transfusion syndrome (TTTS). Initial fetal echocardiogram at 19 weeks showed calcifications of the ascending aorta and pulmonary artery (PA). She underwent utero laser therapy, and despite resolution of the TTTS, her follow-up scans showed progressive calcification of the aorta and PA. Postnatal echocardiogram showed calcification and supravalvar stenosis of the aorta and PA. CT on day of life 6 showed calcifications in the PAs, aortic arch, and descending aorta. Quantification of valvular calcification can be difficult; in our patient, increasing outflow tract gradient on echocardiogram was used to monitor disease progression. Molecular testing revealed an ABCC6 gene mutation. She was started on weekly IV pamidronate (0.1-0.3 mg/kg/week) on day 8 of life then transitioned to oral etidronate (15-20 mg/kg/day). Given progressive supravalvar aortic and pulmonary stenosis, she underwent surgical repair with patch augmentation of the PA and ascending aorta at 4 months old. She has done well post-operatively, continuing on enteral bisphosphonate therapy with no side effects to date. Her identical twin was confirmed to have the same mutation and remains asymptomatic with no calcifications. Aggressive bisphosphonate therapy should be started as soon as possible in patients with infantile arterial calcinosis due to ABCC6 or ENPP1 mutations. Echocardiographic evaluation can be used to monitor disease progression by arterial gradients. Molecular testing is also essential to evaluate for possible co-morbidities in these patients and pregnancy management for the future.
More Related Videos
Related Concept Videos
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Generalized Hooke's Law
Generalized Anxiety Disorder
Viral Mutations
Social Foundations of Self II: The Generalized Other

